INTS vs ULTA
Intensity Therapeutics, Inc. Common stock (INTS) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
INTS does not have a complete income-statement cache yet.
Latest reported ULTA revenue for 2025-02-01 was $11.30B. Net income was $1.20B. Revenue was up 0.8% from 2024-02-03 to 2025-02-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
INTS currently screens at market cap $7.7M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the INTS and ULTA stock pages for the full models.
Not investment advice.